Found 13 matching trials
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry N/A CARTIZ is a prospective observational clinical registry of adults in Mexico...
Show More Location
IMSS Clínica Río Magdalena
Learn More & Join Trial
Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early Detection N/A Validation of biomolecular markers in the circulation and radiomic features...
Show More Location
Istituto Clinico Humanitas
Learn More & Join Trial
Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies N/A In this study, the investigators aim to undertake a retrospective analysis ...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors N/A The investigators retrospectively collected the participants with stage I n...
Show More Location
Jinling Hospital, China
Learn More & Join Trial
CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms N/A The aim of this study is to quantify inter-observer variability in delineat...
Show More Location
Deaprtment of Radiology, IRCCS Ospadale San Raffaele
Learn More & Join Trial
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer NA The researchers are doing this study to find out whether the researchers ca...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Learn More & Join Trial
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer N/A Multi-centre retrospective observational cohort study with optional explora...
Show More Location
The Royal Marsden Hospital NHS Foundation Trust
Learn More & Join Trial
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma N/A Retrospective study in patients with therapy-naive non small cell lung carc...
Show More Location
Multiple Locations
Learn More & Join Trial
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) N/A Pembrolizumab has been approved for first-line locally advanced or metastat...
Show More Learn More & Join Trial
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy N/A I3LUNG is an international project aiming to develop a medical device to pr...
Show More Location
University of Chicago
Learn More & Join Trial